HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

John O Prior Selected Research

Cardiovascular Diseases (Cardiovascular Disease)

1/2024Comparing various AI approaches to traditional quantitative assessment of the myocardial perfusion in [82Rb] PET for MACE prediction.
1/2022Overview of the RGD-Based PET Agents Use in Patients With Cardiovascular Diseases: A Systematic Review.
8/2021Imaging angiogenesis in atherosclerosis in large arteries with 68Ga-NODAGA-RGD PET/CT: relationship with clinical atherosclerotic cardiovascular disease.
12/2017First in-human radiation dosimetry of 68Ga-NODAGA-RGDyK.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


John O Prior Research Topics

Disease

37Neoplasms (Cancer)
02/2024 - 11/2006
10Neoplasm Metastasis (Metastasis)
12/2023 - 06/2007
7Hepatocellular Carcinoma (Hepatoma)
01/2024 - 10/2016
6Prostatic Neoplasms (Prostate Cancer)
03/2021 - 01/2017
5Melanoma (Melanoma, Malignant)
02/2024 - 11/2012
4Cardiovascular Diseases (Cardiovascular Disease)
01/2024 - 12/2017
4Lymphoma (Lymphomas)
01/2018 - 01/2010
4Hyperemia
04/2013 - 10/2006
3Myocardial Infarction
05/2024 - 12/2013
3Glioma (Gliomas)
08/2023 - 03/2016
3Sarcoma (Soft Tissue Sarcoma)
06/2023 - 01/2020
3Inflammation (Inflammations)
10/2021 - 03/2006
3Liver Neoplasms (Liver Cancer)
01/2018 - 10/2016
3Uterine Cervical Neoplasms (Cancer of the Cervix)
03/2016 - 01/2013
3Body Weight (Weight, Body)
07/2011 - 03/2006
3Insulin Resistance
01/2007 - 05/2005
2Myocarditis (Carditis)
12/2023 - 10/2021
2Myositis (Idiopathic Inflammatory Myopathies)
12/2023 - 10/2021
2Uveal melanoma
12/2023 - 02/2012
2Dementia (Dementias)
08/2023 - 01/2023
2Primary Hyperparathyroidism
06/2023 - 01/2023
2Glucose Intolerance
08/2022 - 05/2005
2Communicable Diseases (Infectious Diseases)
12/2021 - 06/2019
2COVID-19
01/2021 - 11/2020
2Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2021 - 01/2009
2Ewing Sarcoma (Sarcoma, Ewing)
01/2021 - 01/2020
2Carcinoma (Carcinomatosis)
01/2020 - 11/2016
2Neuroendocrine Tumors (Neuroendocrine Tumor)
03/2019 - 01/2015
2Cardiomyopathies (Cardiomyopathy)
10/2018 - 04/2013
2Apnea
05/2016 - 03/2016
2Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
10/2013 - 01/2009
2Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
01/2013 - 09/2011
2Type 2 Diabetes Mellitus (MODY)
11/2011 - 05/2005
1ST Elevation Myocardial Infarction
05/2024
1Hypertrophy
01/2024
1Pain (Aches)
11/2023
1Alzheimer Disease (Alzheimer's Disease)
08/2023
1Osteoporosis
01/2023
1Lewy Body Disease (Lewy Body Dementia)
01/2023
1Kidney Calculi (Kidney Stone)
01/2023
1Hypercalcemia (Milk Alkali Syndrome)
01/2023
1Parathyroid Neoplasms (Parathyroid Neoplasm)
01/2023
1Lymphopenia (Lymphocytopenia)
12/2022
1Tuberculosis (Tuberculoses)
12/2022
1Arthritis (Polyarthritis)
12/2022
1Paralysis (Palsy)
11/2022

Drug/Important Bio-Agent (IBA)

17Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
02/2023 - 11/2006
6IntegrinsIBA
05/2024 - 12/2017
6Immune Checkpoint InhibitorsIBA
12/2023 - 08/2019
6RadiopharmaceuticalsIBA
11/2020 - 01/2013
62- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA
05/2016 - 03/2006
468Ga-NODAGA-RGDIBA
05/2024 - 05/2020
4Glucose (Dextrose)FDA LinkGeneric
02/2023 - 01/2009
4AntigensIBA
03/2021 - 01/2019
3SirtuinsIBA
01/2024 - 11/2016
3AlbuminsIBA
12/2023 - 11/2016
3Somatostatin Receptors (Somatostatin Receptor)IBA
10/2021 - 01/2015
3Pentetic Acid (DTPA)FDA LinkGeneric
01/2020 - 04/2017
2RNA (Ribonucleic Acid)IBA
02/2024 - 11/2022
2omega-Chloroacetophenone (Mace)IBA
01/2024 - 12/2013
21- (1,3- carboxypropyl)- 4,7- carboxymethyl- 1,4,7- triazacyclononaneIBA
11/2023 - 11/2016
2Amyloid (Amyloid Fibrils)IBA
08/2023 - 10/2018
2fluorocholineIBA
01/2023 - 01/2019
2NivolumabIBA
01/2023 - 12/2022
2IpilimumabIBA
01/2023 - 12/2022
2lutetium Lu 177 dotatateIBA
12/2022 - 03/2019
2AntibodiesIBA
04/2022 - 01/2017
2Chelating AgentsIBA
04/2022 - 01/2021
2Radioisotopes (Radionuclides)IBA
04/2022 - 01/2017
2Fibroblast Growth Factor-23IBA
01/2022 - 12/2019
21,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
11/2021 - 01/2021
2Biomarkers (Surrogate Marker)IBA
10/2021 - 01/2013
2AcidsIBA
01/2021 - 02/2012
2LigandsIBA
10/2019 - 11/2012
2Choline (Choline Chloride)IBA
01/2019 - 01/2019
2Yttrium-90IBA
01/2018 - 07/2017
2GadoliniumIBA
04/2017 - 02/2012
2Adenosine (Adenocard)FDA LinkGeneric
06/2012 - 11/2011
2Rituximab (Mabthera)FDA Link
09/2011 - 06/2011
2Insulin (Novolin)FDA Link
07/2011 - 05/2005
1arginyl-glycyl-aspartic acidIBA
11/2023
1Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA
08/2023
1Parathyroid Hormone (Parathormone)IBA
01/2023
1pembrolizumabIBA
01/2023
1Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA
01/2023
1Transaminases (Aminotransferases)IBA
08/2022
1LipidsIBA
08/2022
1Triglycerides (Triacylglycerol)IBA
08/2022

Therapy/Procedure

20Therapeutics
02/2024 - 01/2009
9Radiotherapy
01/2024 - 03/2016
5Radioimmunotherapy
01/2021 - 06/2011
4Microspheres (Microsphere)
01/2024 - 01/2017
4Precision Medicine
06/2023 - 12/2017
4Immunotherapy
01/2023 - 01/2020
2Drug Therapy (Chemotherapy)
04/2022 - 06/2011
1Cell- and Tissue-Based Therapy (Cell Therapy)
02/2024
1Oral Surgery (Maxillofacial Surgery)
11/2023
1Gamma Cameras (Gamma Camera)
06/2023
1Minimally Invasive Surgical Procedures
01/2023
1Parathyroidectomy
01/2023